Jynneos vaccine - which has so far been limited - to prevent monkeypox in areas with the highest transmission and need.ACAM2000 vaccine, which is in much greater supply but which has more side effects and cannot be used by everyone, including those who are immunocompromised.The Biden administration will allocate 296,000 doses of Jynneos from a national stockpile to states and territories in the coming weeks, with 56,000 allocated immediately and 1.
"As additional supply becomes available, we will further expand our efforts, making vaccines available to a wider population," Centers for Disease Control and Prevention Director Dr. Rochelle Walensky told reporters. Previously, health officials have been focused on offering the vaccine to individuals with direct contact with a person who has had a confirmed case of monkeypox. The new strategy will expand that definition to include presumed exposures, said Jennifer McQuiston, Deputy Director of CDC’s Division of High Consequence Pathogens and Pathology.
🤔
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.